Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

ORGANOGENESIS APLIGRAPH UNIT-WOUND CARE DISPOSABLE

Active
14RC04306Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Walter Reed National Military Medical Center Acquisition Management Department, representing the General Surgery Clinic, awarded a sole source contract to Organogenesis for the supply of wound care disposables, specifically the Apligraf unit. This contract was executed under the authority of FAR 6.302 due to the fact that Organogenesis was determined to be the only responsible source capable of meeting the specific requirements, and no other suppliers or services adequately satisfied the needs. Consequently, the government did not seek competitive quotes, and the award process was conducted solely at the government's discretion using the SAP system. The contract relates to procurement under solicitation number 14RC04306 and pertains to NAICS code 325414. The place of performance is Bethesda, Maryland, and the Department of Defense's Walter Reed National Military Medical Center is the contracting agency. The point of contact for this procurement is Evelyn L. Brew, the designated Purchase Agent, available via email or phone. This procurement ensures the General Surgery Clinic has access to the necessary specialized wound care disposables to support patient treatment effectively.

General Info

Walter Reed awarded sole source contract to Organogenesis for Apligraf wound care disposables.

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

8901 WISCONSIN AVENUE, BETHESDA, MD, 20889, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Walter Reed National
Contacts1 person available
OfficeBETHESDA, MD, 20889-5600, USA
Office AddressBETHESDA, MD, 20889-5600, USA
Contacts
Evelyn L. BrewPurchase Agent / CONT

Full Description

Show more
The Walter Reed National Military Medical Center (WRNNMMC) Acquisition Management Department, Bethesda, MD on behalf of the General Surgery Clinic has awarded a sole source procurement to Organogenesis. The contract action is for supplies or services for which the Government has solicited and negotiated with only one source under authority of FAR 6.302. Only one responsible source and no other supplies or service satisfied the requirements. This notice of award is NOT a request for competitive price quotes. A determination by the Government not to request quotes was made and responses to this notice are solely within the discretion of the Government. Award was made using SAP.

Similar Contracts

Same NAICS industry code

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS